David Thomson
General Counsel at MANNKIND CORPORATION
Net worth: 2 M $ as of 30/03/2024
Profile
David B.
Thomson has held multiple positions throughout his career.
Currently, he is the Secretary, Executive VP & General Counsel at MannKind Corp.
and also holds the position of Vice President at QrumPharma, Inc. In terms of education, Dr. Thomson completed his undergraduate degree in 1990, followed by a graduate degree in 1991, and a doctorate in 1994 from Queen's University.
He later obtained another graduate degree in 1999 from the University of Toronto.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
MANNKIND CORPORATION
0.18% | 20/03/2024 | 493,482 ( 0.18% ) | 2 M $ | 30/03/2024 |
David Thomson active positions
Companies | Position | Start |
---|---|---|
MANNKIND CORPORATION | General Counsel | 31/12/2001 |
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Corporate Officer/Principal | - |
Training of David Thomson
Queen's University | Doctorate Degree |
University of Toronto | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MANNKIND CORPORATION | Health Technology |
Private companies | 1 |
---|---|
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Health Technology |
- Stock Market
- Insiders
- David Thomson